TY - JOUR
T1 - System-level factors associated with use of outpatient specialty palliative care among patients with advanced cancer
AU - Yu, Justin A.
AU - Ray, Kristin N.
AU - Park, Seo Young
AU - Barry, Amanda
AU - Smith, Cardinale B.
AU - Ellis, Peter G.
AU - Schenker, Yael
N1 - Funding Information:
AUTHOR CONTRIBUTIONS Conception and design: Justin A. Yu, Kristin N. Ray, Peter G. Ellis, Yael Schenker Collection and assembly of data: Justin A. Yu, Amanda Barry Data analysis and interpretation: Justin A. Yu, Kristin N. Park, Seo Young Park, Cardinale B. Smith, Yael Schenker Manuscript writing: All authors Final approval of manuscript: All authors Accountable for all aspects of the work: All authors ACKNOWLEDGMENT Supported by Grant No. K23HD088642 from the National Institute of Child Health and Human Development (K.N.R.) and by Grant No. MRSG PCSM 13-232-01 from the American Cancer Society and National Cancer Institute Grant No. P30CA196521 (C.B.S.). Presented as a poster at the 2018 Annual Assembly of the American Academy of Hospice and Palliative Medicine, Boston, MA, March 14-17, 2018. We thank Brenda Crocker (University of Pittsburgh Medical Center Hillman Cancer Center) for her contributions to data collection.
Publisher Copyright:
© 2018 by American Society of Clinical Oncology
PY - 2019/1/1
Y1 - 2019/1/1
N2 - PURPOSE The proportion of patients with advanced cancer who receive outpatient specialty palliative care (OSPC) is as low as 2.0%. Improved understanding of the system-level factors influencing use of OSPC could inform adaptations to the delivery of palliative care to maximize access. We examined associations between OSPC use among patients with advanced solid tumors and oncology-OSPC clinic colocation and patient travel time to an OSPC clinic. PATIENTS AND METHODS We conducted a retrospective cohort study of patients with advanced solid tumors receiving oncologic treatment between January 1 and December 31, 2016, within a comprehensive cancer center network with well-established, oncology-specific OSPC clinics. Multivariable logistic regression analysis was used to evaluate the associations of clinic colocation and geographic access with OSPC use. RESULTS Of 9,485 patients with advanced solid tumors, 478 (5.0%) received OSPC services in 2016. After controlling for age, sex, marital status, cancer type, insurance, treatment intent, and illness severity, patients whose oncologist practices were colocated with OSPC clinics were more likely to use OSPC (odds ratio [OR], 19.2; 95% CI, 14.1 to 26.2). Compared with patients who lived . 90 minutes from an OSPC clinic, patients with travel times of, 30 minutes (OR, 3.2; 95% CI, 2.2 to 4.6) and 31 to 60 minutes (OR, 2.4; 95% CI, 1.6 to 3.6) were also more likely to use OSPC. CONCLUSION Among patients with advanced solid tumors, colocation of oncology and OSPC clinics and shorter patient travel time were associated with greater odds of using OSPC. Future efforts to increase OSPC use in this population should consider clinic colocation and travel burden.
AB - PURPOSE The proportion of patients with advanced cancer who receive outpatient specialty palliative care (OSPC) is as low as 2.0%. Improved understanding of the system-level factors influencing use of OSPC could inform adaptations to the delivery of palliative care to maximize access. We examined associations between OSPC use among patients with advanced solid tumors and oncology-OSPC clinic colocation and patient travel time to an OSPC clinic. PATIENTS AND METHODS We conducted a retrospective cohort study of patients with advanced solid tumors receiving oncologic treatment between January 1 and December 31, 2016, within a comprehensive cancer center network with well-established, oncology-specific OSPC clinics. Multivariable logistic regression analysis was used to evaluate the associations of clinic colocation and geographic access with OSPC use. RESULTS Of 9,485 patients with advanced solid tumors, 478 (5.0%) received OSPC services in 2016. After controlling for age, sex, marital status, cancer type, insurance, treatment intent, and illness severity, patients whose oncologist practices were colocated with OSPC clinics were more likely to use OSPC (odds ratio [OR], 19.2; 95% CI, 14.1 to 26.2). Compared with patients who lived . 90 minutes from an OSPC clinic, patients with travel times of, 30 minutes (OR, 3.2; 95% CI, 2.2 to 4.6) and 31 to 60 minutes (OR, 2.4; 95% CI, 1.6 to 3.6) were also more likely to use OSPC. CONCLUSION Among patients with advanced solid tumors, colocation of oncology and OSPC clinics and shorter patient travel time were associated with greater odds of using OSPC. Future efforts to increase OSPC use in this population should consider clinic colocation and travel burden.
UR - http://www.scopus.com/inward/record.url?scp=85059828055&partnerID=8YFLogxK
U2 - 10.1200/JOP.18.00234
DO - 10.1200/JOP.18.00234
M3 - Article
C2 - 30407881
AN - SCOPUS:85059828055
VL - 15
SP - E10-E19
JO - JCO Oncology Practice
JF - JCO Oncology Practice
SN - 2688-1527
IS - 1
ER -